Loading chart…
PRE-MARKET
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
Marksans Pharma Limited (MARKSANS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The MARKSANS share price is ₹308.75 (+1.46% today), with a market capitalisation of ₹140B and a price-to-earnings (P/E) ratio of 25.0. MarketRipple tracks the MARKSANS investment thesis, the ripple-chain impact of market events on Marksans Pharma Limited, and the Healthcare sector outlook.
Open
₹305.60
High
₹313.50
Low
₹305.20
Prev. Close
₹304.30
52W High
₹350.95
52W Low
₹155.00
Day range
₹305.20–₹313.50
52-week range
₹155.00–₹350.95
Volume
823K
P/E
25.0
ROE
18.6%
D/E
0.11
Margin
16.5%
Marksans Pharma Limited (NSE: MARKSANS) is currently trading at ₹308.75 (+1.46%).
Marksans Pharma Limited's market capitalization is ₹140B.
Marksans Pharma Limited's price-to-earnings (P/E) ratio is 25.0.
Marksans Pharma Limited operates in the Healthcare sector (Drug Manufacturers - General).
Analyst consensus on Marksans Pharma Limited currently reads neutral, based on 3 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.